30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Switzerland Healthcare Equipment & Supplies

SOPHiA GENETICS SA (SOPH)

Track

Over the last 90 days, SOPHiA GENETICS SA has seen significant insider selling activity, with a net value of over $194,000. While total transactions are high, the net buy percentage remains very low. Notable sales include those by the Chief Financial Officer, President, and Chief Executive Officer, alongside a notable buy by the CFO.
Stock chart
Ticker: SOPH Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
CARDOZA GEORGE
Chief Financial Officer
1 sale — total 100,000 USD
Planned sale 22 Jun 2026
Value US$4,361,593.31 | Price 246.58 | Shares 40,222
Planned sale 22 Jun 2026
Value US$837,403.83 | Price 335.57 | Shares 97,669
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 5.46 | Shares 1,000
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 5.46 | Shares 1,000
Proposed sale 22 Jun 2026
Value US$100,000.00 | Price 5.46 | Shares 1,000
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 5.01 | Shares 1,000
Planned sale 12 Jun 2026
Value US$100,000.00 | Price 4.95 | Shares 1,000
Planned sale 10 Jun 2026
Value US$100,000.00 | Price 5.24 | Shares 1,000
Buy 5 Jun 2026
Value US$100,000.00 | Price 4.95 | Shares 1,000
Buy 5 Jun 2026
Value US$100,000.00 | Price 4.95 | Shares 1,000
Planned sale 26 May 2026
Value US$24,774.00 | Price 4.95 | Shares 5,000
Planned sale 19 May 2026
Value US$20,657.58 | Price 4.60 | Shares 4,486
Planned sale 19 May 2026
Value US$2,797.71 | Price 4.60 | Shares 608
Sale 19 May 2026
Value US$149.90 | Price 4.54 | Shares 33
Planned sale 19 May 2026
Value US$1,747.43 | Price 4.60 | Shares 380
Planned sale 19 May 2026
Value US$3,501.06 | Price 4.60 | Shares 761
Planned sale 19 May 2026
Value US$3,149.27 | Price 4.60 | Shares 684
Planned sale 19 May 2026
Value US$2,800.39 | Price 4.61 | Shares 608
Proposed sale 19 May 2026
Value US$1,782.20 | Price 4.69 | Shares 380
Proposed sale 19 May 2026
Value US$3,207.96 | Price 4.69 | Shares 684
Proposed sale 19 May 2026
Value US$60,904.34 | Price 4.69 | Shares 12,986
Proposed sale 19 May 2026
Value US$73,201.52 | Price 4.69 | Shares 15,608
Proposed sale 19 May 2026
Value US$21,611.52 | Price 4.69 | Shares 4,608
Proposed sale 19 May 2026
Value US$3,569.09 | Price 4.69 | Shares 761
Planned sale 13 May 2026
Value US$18,168.40 | Price 4.54 | Shares 4,000
Planned sale 12 May 2026
Value US$23,344.50 | Price 4.67 | Shares 5,000
Planned sale 12 May 2026
Value US$35,036.83 | Price 4.67 | Shares 7,508
Planned sale 11 May 2026
Value US$43,241.20 | Price 5.09 | Shares 8,500
Planned sale 27 Apr 2026
Value US$24,089.00 | Price 4.82 | Shares 5,000
Planned sale 20 Apr 2026
Value US$1,977.18 | Price 5.20 | Shares 380
Planned sale 20 Apr 2026
Value US$3,954.96 | Price 5.20 | Shares 760
Planned sale 20 Apr 2026
Value US$3,554.27 | Price 5.20 | Shares 684
Planned sale 20 Apr 2026
Value US$3,161.72 | Price 5.20 | Shares 608
Planned sale 20 Apr 2026
Value US$23,349.63 | Price 5.21 | Shares 4,486
Planned sale 20 Apr 2026
Value US$3,164.82 | Price 5.21 | Shares 608
Sale 20 Apr 2026
Value US$167.69 | Price 5.08 | Shares 33
Proposed sale 20 Apr 2026
Value US$68,566.08 | Price 5.28 | Shares 12,986
Proposed sale 20 Apr 2026
Value US$56,010.24 | Price 5.28 | Shares 10,608
Proposed sale 20 Apr 2026
Value US$24,330.24 | Price 5.28 | Shares 4,608
Proposed sale 20 Apr 2026
Value US$2,006.40 | Price 5.28 | Shares 380
Proposed sale 20 Apr 2026
Value US$4,012.80 | Price 5.28 | Shares 760
Proposed sale 20 Apr 2026
Value US$3,611.52 | Price 5.28 | Shares 684
Planned sale 15 Apr 2026
Value US$87,401.69 | Price 5.00 | Shares 17,473
Planned sale 14 Apr 2026
Value US$213,833.58 | Price 4.96 | Shares 43,129
Planned sale 14 Apr 2026
Value US$2,979.78 | Price 4.97 | Shares 600
Planned sale 14 Apr 2026
Value US$13,887.16 | Price 4.96 | Shares 2,800
Planned sale 14 Apr 2026
Value US$7,932.96 | Price 4.96 | Shares 1,600
Planned sale 13 Apr 2026
Value US$21,166.13 | Price 4.77 | Shares 4,442
Planned sale 13 Apr 2026
Value US$16,198.28 | Price 4.76 | Shares 3,400
Planned sale 13 Apr 2026
Value US$4,764.20 | Price 4.76 | Shares 1,000
Planned sale 13 Apr 2026
Value US$20,957.28 | Price 4.76 | Shares 4,399
Planned sale 13 Apr 2026
Value US$16,196.58 | Price 4.76 | Shares 3,400
Planned sale 13 Apr 2026
Value US$4,830.39 | Price 4.76 | Shares 1,014
Planned sale 10 Apr 2026
Value US$11,201.28 | Price 4.67 | Shares 2,400
Planned sale 10 Apr 2026
Value US$17,278.76 | Price 4.69 | Shares 3,687
Planned sale 10 Apr 2026
Value US$17,441.20 | Price 4.68 | Shares 3,725
Planned sale 10 Apr 2026
Value US$17,607.58 | Price 4.72 | Shares 3,732
Planned sale 10 Apr 2026
Value US$40,103.00 | Price 4.72 | Shares 8,500
Planned sale 10 Apr 2026
Value US$17,347.04 | Price 4.68 | Shares 3,706
Planned sale 9 Apr 2026
Value US$9,238.90 | Price 4.74 | Shares 1,950
Planned sale 9 Apr 2026
Value US$9,243.78 | Price 4.74 | Shares 1,950
Planned sale 9 Apr 2026
Value US$9,243.78 | Price 4.74 | Shares 1,950
Planned sale 9 Apr 2026
Value US$9,176.45 | Price 4.74 | Shares 1,936
Planned sale 9 Apr 2026
Value US$9,176.45 | Price 4.74 | Shares 1,936
Planned sale 9 Apr 2026
Value US$9,151.59 | Price 4.74 | Shares 1,931
Planned sale 9 Apr 2026
Value US$9,424.31 | Price 4.74 | Shares 1,988
Planned sale 8 Apr 2026
Value US$13,488.14 | Price 4.84 | Shares 2,786
Planned sale 8 Apr 2026
Value US$13,553.12 | Price 4.84 | Shares 2,800
Planned sale 8 Apr 2026
Value US$13,553.12 | Price 4.84 | Shares 2,800
Planned sale 8 Apr 2026
Value US$13,549.20 | Price 4.84 | Shares 2,800
Planned sale 8 Apr 2026
Value US$13,549.20 | Price 4.84 | Shares 2,800
Planned sale 8 Apr 2026
Value US$18,542.58 | Price 4.85 | Shares 3,824
Planned sale 8 Apr 2026
Value US$13,543.60 | Price 4.84 | Shares 2,800
Planned sale 8 Apr 2026
Value US$13,862.12 | Price 4.85 | Shares 2,861
Planned sale 8 Apr 2026
Value US$6,800.62 | Price 4.85 | Shares 1,403
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-23 2026-06-22 PlS Planned sale
2.0
CARDOZA GEORGE

Chief Financial Officer

Officer
40,222 +41.0%
246.58
US$4,361,593 		40,222 +41.0% 246.58 US$4,361,593
2026-06-23 2026-06-22 PlS Planned sale
Muken Ross

President

Officer
97,669 -7.5%
335.57
US$837,404 		97,669 -7.5% 335.57 US$837,404
2026-06-22 2026-06-22 PrS Proposed sale
ROSS J MUKEN

Officer

Officer
99,165
123.20
US$3,362,266 		99,165 123.20 US$3,362,266
2026-06-22 2026-06-22 PrS Proposed sale
ROSS J MUKEN

Officer

Officer
1,000
5.46
US$100,000 		1,000 5.46 US$100,000
2026-06-22 2026-06-22 PrS Proposed sale
2.0
GEORGE CARDOZA

Officer

Officer
1,000
5.46
US$100,000 		1,000 5.46 US$100,000
2026-06-17 2026-06-15 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
1,000 -0.6%
5.01
US$100,000 		1,000 -0.6% 5.01 US$100,000
2026-06-15 2026-06-12 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
1,000 -2.0%
4.95
US$100,000 		1,000 -2.0% 4.95 US$100,000
2026-06-11 2026-06-10 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
1,000 -0.2%
5.24
US$100,000 		1,000 -0.2% 5.24 US$100,000
2026-06-05 2026-06-05 B Purchase
2.0
CARDOZA GEORGE

Chief Financial Officer

Officer
1,000 +6.9%
4.95
US$100,000 		1,000 +6.9% 4.95 US$100,000
2026-06-05 2026-06-05 B Purchase
2.0
CARDOZA GEORGE

Chief Financial Officer

Officer
1,000 +6.9%
4.95
US$100,000 		1,000 +6.9% 4.95 US$100,000
2026-06-01 2026-05-26 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
5,000 -2.0%
4.95
US$24,774 		5,000 -2.0% 4.95 US$24,774
2026-05-20 2026-05-19 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
4,486 -0.1%
4.60
US$20,658 		4,486 -0.1% 4.60 US$20,658
2026-05-20 2026-05-19 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
608 -0.1%
4.60
US$2,798 		608 -0.1% 4.60 US$2,798
2026-05-20 2026-05-19 S Sale
Puylaert Kevin

Chief Sales Officer

Officer
33 -0.0%
4.54
US$150 		33 -0.0% 4.54 US$150
2026-05-20 2026-05-19 PlS Planned sale
Valente Manuela

Chief People Officer

Officer
380 -0.2%
4.60
US$1,747 		380 -0.2% 4.60 US$1,747
2026-05-20 2026-05-19 PlS Planned sale
Muken Ross

President

Officer
761 -0.1%
4.60
US$3,501 		761 -0.1% 4.60 US$3,501
2026-05-20 2026-05-19 PlS Planned sale
Van Well Daan

Chief Legal Officer

Officer
684 -0.2%
4.60
US$3,149 		684 -0.2% 4.60 US$3,149
2026-05-20 2026-05-19 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
608 -0.2%
4.61
US$2,800 		608 -0.2% 4.61 US$2,800
2026-05-19 2026-05-19 PrS Proposed sale
MANUELA VALENTE

Officer

Officer
380
4.69
US$1,782 		380 4.69 US$1,782
2026-05-19 2026-05-19 PrS Proposed sale
DAAN GUIDO MARIA VAN WELL

Officer

Officer
684
4.69
US$3,208 		684 4.69 US$3,208
2026-05-19 2026-05-19 PrS Proposed sale
JURGI CAMBLONG

Director; Officer

Executive Director
12,986
4.69
US$60,904 		12,986 4.69 US$60,904
2026-05-19 2026-05-19 PrS Proposed sale
PHILIPPE MENU

Officer

Officer
15,608
4.69
US$73,202 		15,608 4.69 US$73,202
2026-05-19 2026-05-19 PrS Proposed sale
ZHENYU XU

Officer

Officer
4,608
4.69
US$21,612 		4,608 4.69 US$21,612
2026-05-19 2026-05-19 PrS Proposed sale
ROSS J MUKEN

Officer

Officer
761
4.69
US$3,569 		761 4.69 US$3,569
2026-05-14 2026-05-13 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
4,000 -0.6%
4.54
US$18,168 		4,000 -0.6% 4.54 US$18,168
2026-05-13 2026-05-12 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
5,000 -1.9%
4.67
US$23,344 		5,000 -1.9% 4.67 US$23,344
2026-05-13 2026-05-12 PlS Planned sale
HIBBS KATHY L
Non-Executive Director
7,508 -7.7%
4.67
US$35,037 		7,508 -7.7% 4.67 US$35,037
2026-05-12 2026-05-11 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
8,500 -0.2%
5.09
US$43,241 		8,500 -0.2% 5.09 US$43,241
2026-04-28 2026-04-27 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
5,000 -1.9%
4.82
US$24,089 		5,000 -1.9% 4.82 US$24,089
2026-04-21 2026-04-20 PlS Planned sale
Valente Manuela

Chief People Officer

Officer
380 -0.2%
5.20
US$1,977 		380 -0.2% 5.20 US$1,977
2026-04-21 2026-04-20 PlS Planned sale
Muken Ross

President

Officer
760 -0.1%
5.20
US$3,955 		760 -0.1% 5.20 US$3,955
2026-04-21 2026-04-20 PlS Planned sale
Van Well Daan

Chief Legal Officer

Officer
684 -0.2%
5.20
US$3,554 		684 -0.2% 5.20 US$3,554
2026-04-21 2026-04-20 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
608 -0.2%
5.20
US$3,162 		608 -0.2% 5.20 US$3,162
2026-04-21 2026-04-20 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
4,486 -0.1%
5.21
US$23,350 		4,486 -0.1% 5.21 US$23,350
2026-04-21 2026-04-20 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
608 -0.1%
5.21
US$3,165 		608 -0.1% 5.21 US$3,165
2026-04-21 2026-04-20 S Sale
Puylaert Kevin

Chief Sales Officer

Officer
33 -0.0%
5.08
US$168 		33 -0.0% 5.08 US$168
2026-04-20 2026-04-20 PrS Proposed sale
JURGI CAMBLONG

Director; Officer

Executive Director
12,986
5.28
US$68,566 		12,986 5.28 US$68,566
2026-04-20 2026-04-20 PrS Proposed sale
PHILIPPE MENU

Officer

Officer
10,608
5.28
US$56,010 		10,608 5.28 US$56,010
2026-04-20 2026-04-20 PrS Proposed sale
ZHENYU XU

Officer

Officer
4,608
5.28
US$24,330 		4,608 5.28 US$24,330
2026-04-20 2026-04-20 PrS Proposed sale
MANUELA VALENTE

Officer

Officer
380
5.28
US$2,006 		380 5.28 US$2,006
2026-04-20 2026-04-20 PrS Proposed sale
ROSS J MUKEN

Officer

Officer
760
5.28
US$4,013 		760 5.28 US$4,013
2026-04-20 2026-04-20 PrS Proposed sale
DAAN GUIDO MARIA VAN WELL

Officer

Officer
684
5.28
US$3,612 		684 5.28 US$3,612
2026-04-16 2026-04-15 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
17,473 -0.5%
5.00
US$87,402 		17,473 -0.5% 5.00 US$87,402
2026-04-16 2026-04-14 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
43,129 -1.2%
4.96
US$213,834 		43,129 -1.2% 4.96 US$213,834
2026-04-16 2026-04-14 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
600 -0.1%
4.97
US$2,980 		600 -0.1% 4.97 US$2,980
2026-04-16 2026-04-14 PlS Planned sale
Muken Ross

President

Officer
2,800 -0.4%
4.96
US$13,887 		2,800 -0.4% 4.96 US$13,887
2026-04-16 2026-04-14 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
1,600 -0.6%
4.96
US$7,933 		1,600 -0.6% 4.96 US$7,933
2026-04-14 2026-04-13 PlS Planned sale
Muken Ross

President

Officer
4,442 -0.6%
4.77
US$21,166 		4,442 -0.6% 4.77 US$21,166
2026-04-14 2026-04-13 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
3,400 -1.3%
4.76
US$16,198 		3,400 -1.3% 4.76 US$16,198
2026-04-14 2026-04-13 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
1,000 -0.4%
4.76
US$4,764 		1,000 -0.4% 4.76 US$4,764
2026-04-14 2026-04-13 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
4,399 -0.1%
4.76
US$20,957 		4,399 -0.1% 4.76 US$20,957
2026-04-14 2026-04-13 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
3,400 -0.5%
4.76
US$16,197 		3,400 -0.5% 4.76 US$16,197
2026-04-14 2026-04-13 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
1,014 -0.2%
4.76
US$4,830 		1,014 -0.2% 4.76 US$4,830
2026-04-14 2026-04-10 PlS Planned sale
Van Well Daan

Chief Legal Officer

Officer
2,400 -0.7%
4.67
US$11,201 		2,400 -0.7% 4.67 US$11,201
2026-04-14 2026-04-10 PlS Planned sale
Muken Ross

President

Officer
3,687 -0.5%
4.69
US$17,279 		3,687 -0.5% 4.69 US$17,279
2026-04-14 2026-04-10 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
3,725 -1.3%
4.68
US$17,441 		3,725 -1.3% 4.68 US$17,441
2026-04-14 2026-04-10 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
3,732 -0.1%
4.72
US$17,608 		3,732 -0.1% 4.72 US$17,608
2026-04-14 2026-04-10 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
8,500 -0.2%
4.72
US$40,103 		8,500 -0.2% 4.72 US$40,103
2026-04-14 2026-04-10 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
3,706 -0.6%
4.68
US$17,347 		3,706 -0.6% 4.68 US$17,347
2026-04-10 2026-04-09 PlS Planned sale
Muken Ross

President

Officer
1,950 -0.3%
4.74
US$9,239 		1,950 -0.3% 4.74 US$9,239
2026-04-10 2026-04-09 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
1,950 -0.1%
4.74
US$9,244 		1,950 -0.1% 4.74 US$9,244
2026-04-10 2026-04-09 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
1,950 -0.1%
4.74
US$9,244 		1,950 -0.1% 4.74 US$9,244
2026-04-10 2026-04-09 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
1,936 -0.3%
4.74
US$9,176 		1,936 -0.3% 4.74 US$9,176
2026-04-10 2026-04-09 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
1,936 -0.3%
4.74
US$9,176 		1,936 -0.3% 4.74 US$9,176
2026-04-10 2026-04-09 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
1,931 -0.7%
4.74
US$9,152 		1,931 -0.7% 4.74 US$9,152
2026-04-10 2026-04-09 PlS Planned sale
Van Well Daan

Chief Legal Officer

Officer
1,988 -0.6%
4.74
US$9,424 		1,988 -0.6% 4.74 US$9,424
2026-04-10 2026-04-08 PlS Planned sale
Muken Ross

President

Officer
2,786 -0.4%
4.84
US$13,488 		2,786 -0.4% 4.84 US$13,488
2026-04-10 2026-04-08 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
2,800 -0.1%
4.84
US$13,553 		2,800 -0.1% 4.84 US$13,553
2026-04-10 2026-04-08 PlS Planned sale
Camblong Jurgi

Chief Executive Officer

Executive Director
2,800 -0.1%
4.84
US$13,553 		2,800 -0.1% 4.84 US$13,553
2026-04-10 2026-04-08 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
2,800 -0.4%
4.84
US$13,549 		2,800 -0.4% 4.84 US$13,549
2026-04-10 2026-04-08 PlS Planned sale
Xu Zhenyu

Chief Scientific Officer

Officer
2,800 -0.4%
4.84
US$13,549 		2,800 -0.4% 4.84 US$13,549
2026-04-10 2026-04-08 PlS Planned sale
Valente Manuela

Chief People Officer

Officer
3,824 -1.7%
4.85
US$18,543 		3,824 -1.7% 4.85 US$18,543
2026-04-10 2026-04-08 PlS Planned sale
Menu Philippe

Chief Medical Officer

Officer
2,800 -1.0%
4.84
US$13,544 		2,800 -1.0% 4.84 US$13,544
2026-04-10 2026-04-08 PlS Planned sale
Van Well Daan

Chief Legal Officer

Officer
2,861 -0.8%
4.85
US$13,862 		2,861 -0.8% 4.85 US$13,862
2026-04-10 2026-04-08 PlS Planned sale
2.0
CARDOZA GEORGE

Chief Financial Officer

Officer
1,403 -0.5%
4.85
US$6,801 		1,403 -0.5% 4.85 US$6,801
Explore more

More insider trading research around SOPHiA GENETICS SA

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in Europe